The Centers for Disease Control and Prevention (CDC) is expecting three to 10-month nationwide shortage of Aplisol, a product of Par Pharmaceuticals, and one of two purified-protein derivative tuberculin antigens licensed by the Food and Drug Administration for use in performing tuberculin skin tests. Read the
CDC’s Laboratory Outreach Communication System Lab Advisory to learn more about recommendations for patient care and public health practice.
